Biotechnology Pfizer’s Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds – Pfizer (NYSE:PFE) Read more
Biotechnology Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer’s Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call – Main Takeaways – Pfizer (NYSE:PFE) Read more
Stockmarkets Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit Reuters via biedexmarkets.com Read more
Biotechnology Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle – Pfizer (NYSE:PFE) Read more
Eurozone US Stocks Edge Lower; Pfizer Reports Surprise Profit – Agrify (NASDAQ:AGFY), Agape ATP (NASDAQ:ATPC) Read more
Biotechnology Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand, Sticks To 2024 Guidance – Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer’s COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label – Pfizer (NYSE:PFE) Read more
Stockmarkets Pfizer posts surprise 4th quarter profit on fewer Paxlovid returns Reuters via biedexmarkets.com Read more